Budget impact of somatostatin analogs as treatment for metastatic gastroenteropancreatic neuroendocrine tumors in US hospitals

por Ortendahl, Jesse D, Pulgar, Sonia J, Mirakhur, Beloo, Cox, David, Bentley, Tanya GK, Phan, Alexandria T
Publicado 2017

Treatment Patterns and Health Resource Use Among Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors Treated at a Tertiary Referral Center

por Jalbert, Jessica J., Casciano, Roman, Meng, Jie, Brais, Lauren K., Pulgar, Sonia J., Berthon, Anthony, Dinet, Jerome, Kulke, Matthew H.
Publicado 2020